The Epidemiology of Major Depressive Disorder, JAMA, vol.289, issue.23, pp.3095-105, 2003. ,
DOI : 10.1001/jama.289.23.3095
Cost of depression in Europe, J Ment Health Policy Econ, vol.9, issue.2, pp.87-98, 2006. ,
Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand Suppl, issue.420, pp.21-28, 2004. ,
Prescription patterns of antidepressants: findings from a US claims database, Current Medical Research and Opinion, vol.26, issue.6, 2010. ,
DOI : 10.1185/03007991003772096
Antidepressant monotherapy treatment for depression: a claims database analysis of treatment changes and duration of treatment, Clin Ther, 2010. ,
Evolution of antidepressants consumption in the USA and in nine different European countries during the last decade, 2010. ,
Long-term treatments of recurrent depressive disorders, J Clin Psychiatry, vol.53, pp.32-44, 1992. ,
The Role of Residual Subthreshold Depressive Symptoms in Early Episode Relapse in Unipolar Major Depressive Disorder, Archives of General Psychiatry, vol.56, issue.8, pp.764-769, 1999. ,
DOI : 10.1001/archpsyc.56.8.763
Essential Pharmacology of Depression and Bipolar Disorder, 2008. ,
Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issues, European Psychiatry, vol.16, issue.6, pp.327-362, 2001. ,
DOI : 10.1016/S0924-9338(01)00587-9
Relapse after recovery from unipolar depression: A critical review., Psychological Bulletin, vol.104, issue.1, pp.84-96, 1988. ,
DOI : 10.1037/0033-2909.104.1.84
The Effects of Adherence to Antidepressant Treatment Guidelines on Relapse and Recurrence of Depression, Archives of General Psychiatry, vol.55, issue.12, pp.1128-1160, 1998. ,
DOI : 10.1001/archpsyc.55.12.1128
Risk for recurrence in depression, Clinical Psychology Review, vol.27, issue.8, pp.959-85, 2007. ,
DOI : 10.1016/j.cpr.2007.02.005
New strategies for treating chronic depression, J Clin Psychiatry, vol.61, issue.11, pp.42-47, 2000. ,
Management of nonresponse and intolerance: switching strategies, J Clin Psychiatry, vol.61, issue.2, pp.10-12, 2000. ,
New approaches to the treatment of refractory depression, J Clin Psychiatry, vol.61, issue.1, pp.26-32, 2000. ,
Definition, Assessment, and Staging of Treatment???Resistant Refractory Major Depression: A Review of Current Concepts and Methods, The Canadian Journal of Psychiatry, vol.58, issue.8, pp.46-54, 2007. ,
DOI : 10.1177/070674370705200108
Prevalence and management of treatment-resistant depression, J Clin Psychiatry, vol.68, issue.8, pp.17-25, 2007. ,
The WHO World Mental Health Surveys, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00585164
Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD), J Clin Psychiatry, vol.68, issue.2, pp.3-9, 2007. ,
The National Comorbidity Survey Replication (NCS-R): background and aims, International Journal of Methods in Psychiatric Research, vol.285, issue.2, pp.60-68, 2004. ,
DOI : 10.1002/mpr.166
The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics, Arch Gen Psychiatry, 1984. ,
DOI : 10.1001/archpsyc.1984.01790210016003
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys, JAMA, vol.291, issue.2721, pp.2581-90, 2004. ,
The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods, International Journal of Methods in Psychiatric Research, vol.159, issue.2, pp.55-67, 2002. ,
DOI : 10.1002/mpr.123
Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand Suppl, issue.420, pp.8-20, 2004. ,
Usage des psychotropes et troubles psychiatriques en France : r??sultats de l?????tude ??pid??miologique ESEMeD/MHEDEA 2000/ (ESEMeD) en population g??n??rale, L'Enc??phale, vol.31, issue.2, pp.195-206, 2005. ,
DOI : 10.1016/S0013-7006(05)82386-3
Depression in the community, International Clinical Psychopharmacology, vol.12, issue.1 ,
DOI : 10.1097/00004850-199701000-00003
Depressive disorders in Europe: prevalence figures from the ODIN study, The British Journal of Psychiatry, vol.179, issue.4, pp.308-324, 2001. ,
DOI : 10.1192/bjp.179.4.308
Prevalence and treatment of mental disorders, N Engl J Med, issue.33, 1990. ,
Prevalence of mental disorders based on general population surveys, Social Psychiatry and Psychiatric Epidemiology, vol.162, issue.suppl. 420, pp.537-583, 2007. ,
DOI : 10.1007/s00127-007-0204-1
The National Comorbidity Survey Replication (NCS-R): Cornerstone in Improving Mental Health and Mental Heath care in the United States, The WHO Wolrd Mental Health Surveys, pp.165-209, 2008. ,
Parental depression and depression in offspring: evidence for familial characteristics and subtypes?, Journal of Psychiatric Research, vol.36, issue.4, pp.237-283, 2002. ,
DOI : 10.1016/S0022-3956(02)00015-8
Family history of mood disorder and characteristics of major depressive disorder: A STAR???D (sequenced treatment alternatives to relieve depression) study, Journal of Psychiatric Research, vol.41, issue.3-4, pp.3-4214, 2007. ,
DOI : 10.1016/j.jpsychires.2006.02.005
Genetic Epidemiology of Major Depression: Review and Meta-Analysis, American Journal of Psychiatry, vol.157, issue.10, pp.1552-62, 2000. ,
DOI : 10.1176/appi.ajp.157.10.1552
Mortality associated with depression, Social Psychiatry and Psychiatric Epidemiology, vol.262, issue.4, pp.594-601, 2008. ,
DOI : 10.1007/s00127-008-0323-3
Mortality among patients with psychiatric illness. A ten-year case register study in an area with a community-based system of care, The British Journal of Psychiatry, vol.166, issue.6, pp.783-791, 1995. ,
DOI : 10.1192/bjp.166.6.783
Depression, Cardiovascular Disease, Diabetes, and Two-Year Mortality Among Older, Primary-Care Patients, The American Journal of Geriatric Psychiatry, vol.13, issue.9, pp.748-55, 2005. ,
DOI : 10.1097/00019442-200509000-00002
Recurrent depression. Its overwhelming burden. Treatment of Recurrent Depression, pp.1-18, 2001. ,
Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety, J Clin Psychiatry, vol.60, issue.43 7, pp.54-61, 1999. ,
Depression, Mayo Clinic Proceedings, vol.76, issue.3, pp.20-26, 1999. ,
DOI : 10.4065/76.3.347
New Onset Depression Following Myocardial Infarction Predicts Cardiac Mortality, Psychosomatic Medicine, vol.70, issue.4, pp.450-455, 2008. ,
DOI : 10.1097/PSY.0b013e31816a74de
Developing depression after a myocardial infarction increases risk of cardiac mortality but pre-existing depression does not. Evid Based Ment Health, Feb, vol.12, issue.1, p.8, 2009. ,
Effect of Depression on Late (8 years) Mortality After Myocardial Infarction, The American Journal of Cardiology, vol.101, issue.5, pp.602-608, 2008. ,
DOI : 10.1016/j.amjcard.2007.10.021
Depression: a long-term illness, Br J Psychiatry, issue.48, 1994. ,
The Prevalence of Comorbid Depression in Adults With Diabetes: A meta-analysis, Diabetes Care, vol.24, issue.6, 2001. ,
DOI : 10.2337/diacare.24.6.1069
Association of depression and diabetes complications: a meta-analysis, Psychosom Med, issue.50, 2001. ,
Social Functioning in Depression, The Journal of Clinical Psychiatry, vol.61, issue.4, 2000. ,
DOI : 10.4088/JCP.v61n0405
The incidence of anxiety and depression among employees-the role of psychosocial work characteristics, Depression and Anxiety, vol.11, issue.11, pp.1040-1048, 2009. ,
DOI : 10.1002/da.20516
Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders, Journal of Affective Disorders, vol.108, issue.1-2, pp.49-58, 2008. ,
DOI : 10.1016/j.jad.2007.06.014
The Prevalence and Correlates of Workplace Depression in the National Comorbidity Survey Replication, Journal of Occupational and Environmental Medicine, vol.50, issue.4, pp.381-90, 2008. ,
DOI : 10.1097/JOM.0b013e31816ba9b8
Recovery from depression, work productivity, and health care costs among primary care patients, General Hospital Psychiatry, vol.22, issue.3, pp.153-62, 2000. ,
DOI : 10.1016/S0163-8343(00)00072-4
Severity of mood symptoms and work productivity in people treated for bipolar disorder, Bipolar Disorders, vol.57, issue.6, pp.718-743, 2008. ,
DOI : 10.1111/j.1399-5618.2008.00581.x
Prevalence and Effects of Mood Disorders on Work Performance in a Nationally Representative Sample of U.S. Workers, American Journal of Psychiatry, vol.163, issue.9, pp.1561-1569, 2006. ,
DOI : 10.1176/ajp.2006.163.9.1561
Alternative projections of mortality and disability by cause 1990???2020: Global Burden of Disease Study, The Lancet, vol.349, issue.9064, pp.1498-504, 1997. ,
DOI : 10.1016/S0140-6736(96)07492-2
Impact of Illness and Its Treatment on Workplace Costs: Regulatory and Measurement Issues, Journal of Occupational and Environmental Medicine, vol.43, issue.1, pp.56-63, 2001. ,
DOI : 10.1097/00043764-200101000-00011
The Economic Burden of Depression in the United States, The Journal of Clinical Psychiatry, vol.64, issue.12, pp.1465-75, 2000. ,
DOI : 10.4088/JCP.v64n1211
Prévalence et prise en charge médicale de la dépression en 1996-1997. CREDES, 1999. ,
Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand Suppl, issue.420, pp.47-54, 2004. ,
Twelve-Month Use of Mental Health Services in the United States, Archives of General Psychiatry, vol.62, issue.6, pp.629-669, 2005. ,
DOI : 10.1001/archpsyc.62.6.629
Differences in Lifetime Use of Services for Mental Health Problems in Six European Countries, Psychiatric Services, vol.58, issue.2, pp.213-233, 2007. ,
DOI : 10.1176/ps.2007.58.2.213
A New Paradigm for Treating Depression in the Primary Care Setting, 2002. ,
Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand Suppl, issue.420, pp.55-64, 2004. ,
Treatment adequacy for anxiety and depressive disorders in six European countries, The British Journal of Psychiatry, vol.190, issue.2, pp.172-175, 2007. ,
DOI : 10.1192/bjp.bp.106.023507
Cognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and Mediators, Psychiatric Clinics of North America, vol.33, issue.3, 2010. ,
DOI : 10.1016/j.psc.2010.04.005
New approaches to developing antidepressants by enhancing monoaminergic neurotransmission, Expert Opinion on Investigational Drugs, vol.283, issue.975, pp.531-574, 2003. ,
DOI : 10.1046/j.1460-9568.2000.00982.x
Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal? Evid Based Ment Health, pp.101-105, 2009. ,
Metareview on Short-Term Effectiveness and Safety of Antidepressants for Depression: An Evidence-Based Approach to Inform Clinical Practice, The Canadian Journal of Psychiatry, vol.65, issue.12, pp.553-62, 2007. ,
DOI : 10.1016/S0009-9236(02)17634-X
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, The Lancet, vol.373, issue.9665, pp.746-58, 2009. ,
DOI : 10.1016/S0140-6736(09)60046-5
Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: A meta-analysis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.33, issue.1, pp.118-145, 2009. ,
DOI : 10.1016/j.pnpbp.2008.10.018
) in Major Depression, The Journal of Clinical Psychiatry, vol.70, issue.suppl 5, pp.23-30, 2009. ,
DOI : 10.4088/JCP.8157su1c.05
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care, The World Journal of Biological Psychiatry, vol.34, issue.3, pp.67-104, 2007. ,
DOI : 10.1097/00004583-199611000-00018
Treatment of major depression Clin Pract Guide 12, 5. 1993. rockville, Md, US Department of health and Human services Ref Type: Unpublished Work (81) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy, J Affect Disord, vol.117, issue.80 1, pp.26-43, 2009. ,
Major Depressive Disorder Treatment Guidelines in America and Europe, The Journal of Clinical Psychiatry, vol.71, issue.suppl E1, 2010. ,
DOI : 10.4088/JCP.9058se1c.04gry
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review, The Lancet, vol.361, issue.9358, pp.653-61, 2003. ,
DOI : 10.1016/S0140-6736(03)12599-8
Continuity Is the Main Challenge in Treating Major Depressive Disorder in Psychiatric Care, The Journal of Clinical Psychiatry, vol.66, issue.02, pp.220-227, 2005. ,
DOI : 10.4088/JCP.v66n0210
Escitalopram Maintenance Treatment for Prevention of Recurrent Depression, The Journal of Clinical Psychiatry, vol.67, issue.11, pp.1767-75, 2006. ,
DOI : 10.4088/JCP.v67n1115
Milnacipran efficacy in the prevention of recurrent depression: a 12-month placebo-controlled study. Milnacipran recurrence prevention study group, Int Clin Psychopharmacol, 2000. ,
A Randomized, Placebo-Controlled Trial of Sertraline for Prophylactic Treatment of Highly Recurrent Major Depressive Disorder, American Journal of Psychiatry, vol.161, issue.5, pp.836-878, 2004. ,
DOI : 10.1176/appi.ajp.161.5.836
Five-Year Outcome for Maintenance Therapies in Recurrent Depression, Archives of General Psychiatry, vol.49, issue.10, pp.769-73, 1992. ,
DOI : 10.1001/archpsyc.1992.01820100013002
Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR???D) study, Psychiatric Clinics of North America, vol.26, issue.2, pp.457-94, 2003. ,
DOI : 10.1016/S0193-953X(02)00107-7
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Part 1: study design, J Psychosoc Nurs Ment Health Serv, 2008. ,
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Part 2: Study outcomes, J Psychosoc Nurs Ment Health Serv, issue.94, 2008. ,
Evaluation of outcomes with citalopram for depression using measurementbased care in STAR*D: implications for clinical practice, Am J Psychiatry, 2006. ,
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression, New England Journal of Medicine, vol.354, issue.12, pp.1231-1273, 2006. ,
DOI : 10.1056/NEJMoa052963
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report, American Journal of Psychiatry, vol.163, issue.7, pp.1161-72, 2006. ,
DOI : 10.1176/ajp.2006.163.7.1161
Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report, American Journal of Psychiatry, vol.163, issue.9, pp.1531-1572, 2006. ,
DOI : 10.1176/ajp.2006.163.9.1531
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report, Am J Psychiatry, issue.99, 2006. ,
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, Am J Psychiatry, issue.100, 2006. ,
Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study, European Journal of Clinical Pharmacology, vol.56, issue.12, pp.923-932, 2001. ,
DOI : 10.1007/s002280000234
Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors, Acta Psychiatrica Scandinavica, vol.56, issue.6, pp.17-25, 2000. ,
DOI : 10.1002/(SICI)1099-1557(199707)6:4<235::AID-PDS293>3.3.CO;2-V
Antidepressant Prescribing Practices of Outpatient Psychiatrists, Archives of General Psychiatry, vol.55, issue.4, pp.310-316, 1998. ,
DOI : 10.1001/archpsyc.55.4.310
National trends in the outpatient treatment of depression, JAMA, vol.287, issue.2, pp.203-212, 2002. ,
National Patterns in Antidepressant Treatment by Psychiatrists and General Medical Providers, The Journal of Clinical Psychiatry, vol.69, issue.7, pp.1064-74, 2008. ,
DOI : 10.4088/JCP.v69n0704
Self-reported psychotropic drug use and associated factors in a French community sample, Psychological Medicine, vol.18, issue.01, 1992. ,
DOI : 10.1016/0165-0327(90)90009-W
Which patients receive antidepressants? A `real world' telephone study, Journal of Affective Disorders, vol.49, issue.1, 1998. ,
DOI : 10.1016/S0165-0327(97)00193-6
[Pharmacoepidemiologic study of the use of antidepressant drugs in the general population], Encephale, vol.22, issue.110 1, pp.39-48, 1996. ,
Médicaments psychotropes : consommation et pratiques de prescription en France métropolitaine. I. Données nationales, Rev Med Assu Mal, vol.34, pp.75-83, 2000. ,
Incidence and determinants of long-term use of antidepressants, European Journal of Clinical Pharmacology, vol.60, issue.1, pp.57-61, 2004. ,
DOI : 10.1007/s00228-004-0726-3
Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands, Pharmacoepidemiology and Drug Safety, vol.90, issue.5, pp.338-381, 2006. ,
DOI : 10.1002/pds.1223
Clinical factors influencing the prescription of antidepressants and benzodiazepines:, Journal of Affective Disorders, vol.110, issue.1-2, pp.84-93, 2008. ,
DOI : 10.1016/j.jad.2008.01.011
Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression, The British Journal of Psychiatry, vol.177, issue.2, 2000. ,
DOI : 10.1192/bjp.177.2.163
Clinical importance of long-term antidepressant treatment, The British Journal of Psychiatry, vol.179, issue.42, pp.4-8, 2001. ,
DOI : 10.1192/bjp.179.42.s4
[Epidemiology, public health and medical rates databases]. Rev Epidemiol Sante Publique, pp.113-120, 2004. ,
The Nordic Countries as a Cohort for Pharmacoepidemiological Research, Basic & Clinical Pharmacology & Toxicology, vol.63, issue.2, pp.86-94, 2010. ,
DOI : 10.1111/j.1742-7843.2009.00494.x
The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis, Am J Psychiatry, vol.145, issue.11, pp.1351-1358, 1988. ,
Marketing ???mind mechanics???: Decoding antidepressant drug advertisements, Social Science & Medicine, vol.22, issue.10, pp.1047-58, 1986. ,
DOI : 10.1016/0277-9536(86)90205-4
Drug advertisements and the medicalization of unipolar depression in women. Health Care Women Int, pp.229-271, 1995. ,
Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians? diagnoses, Journal of Affective Disorders, vol.78, issue.2, pp.131-171, 2004. ,
DOI : 10.1016/S0165-0327(02)00237-9
The Diagnostic Inventory for Depression: A self-report scale to diagnose DSM-IV major depressive disorder, Journal of Clinical Psychology, vol.44, issue.1, pp.87-110, 2004. ,
DOI : 10.1002/jclp.10207
Increased Use of Antidepressants in Canada: 1981???2000, Annals of Pharmacotherapy, vol.52, issue.9, pp.1375-1384, 2002. ,
DOI : 10.1345/aph.1A331
Antidepressant utilization in Canada, Social Psychiatry and Psychiatric Epidemiology, vol.41, issue.Suppl 1, 2005. ,
DOI : 10.1007/s00127-005-0968-0
Trends in service use and treatment for mental disorders in adults throughout Great Britain, The British Journal of Psychiatry, vol.185, issue.5, pp.378-84, 2004. ,
DOI : 10.1192/bjp.185.5.378
Increase in Antidepressant Medication in the US Adult Population between 1990 and 2003, Psychotherapy and Psychosomatics, vol.77, issue.2, pp.83-92, 1990. ,
DOI : 10.1159/000112885
Trends in psychotropic medication use among U.S. adults, Pharmacoepidemiology and Drug Safety, vol.51, issue.5, 2007. ,
DOI : 10.1002/pds.1367
Antidepressant utilization in primary care in a Spanish region, Social Psychiatry and Psychiatric Epidemiology, vol.20, issue.Suppl 1, pp.181-189, 2000. ,
DOI : 10.1007/s00127-006-0149-9
Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates, Social Psychiatry and Psychiatric Epidemiology, vol.34, issue.3, 1999. ,
DOI : 10.1007/s001270050127
A comparison of antidepressant use in Nova Scotia, Canada and Australia, Pharmacoepidemiology and Drug Safety, vol.35, issue.9, pp.697-706, 2008. ,
DOI : 10.1002/pds.1541
Are we going to increase the use of antidepressants up to that of benzodiazepines?, European Journal of Clinical Pharmacology, vol.72, issue.9, pp.629-663, 2004. ,
DOI : 10.1007/s00228-004-0810-8
National Patterns of Medication Treatment for Depression, 1987 to 2001, The Primary Care Companion to The Journal of Clinical Psychiatry, vol.03, issue.06, pp.232-237, 1987. ,
DOI : 10.4088/PCC.v03n0611
Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis, Pharmacoepidemiology and Drug Safety, vol.20, issue.10, 2007. ,
DOI : 10.1002/pds.1405
Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database, European Journal of Clinical Pharmacology, vol.57, issue.8, 2001. ,
DOI : 10.1007/s002280100361
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement, European Journal of Clinical Pharmacology, vol.59, issue.11, pp.825-856, 2004. ,
DOI : 10.1007/s00228-003-0692-1
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years, Pharmacoepidemiol Drug Saf, issue.140, 2003. ,
Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database, BMJ, vol.339, issue.oct15 2, p.3999, 2009. ,
DOI : 10.1136/bmj.b3999
les ventes d'antidépresseurs entre http://www sante gouv fr/drees/serieetudes, 1980. ,
Rapport sur le bon usage des médicaments psychotropes, 2006. ,
Managed care and medication compliance: Implications for chronic depression, The Journal of Behavioral Health Services & Research, vol.30, issue.Suppl. 1, pp.367-76, 1998. ,
DOI : 10.1007/BF02287508
Newer agents for the treatment of painful diabetic peripheral neuropathy, Current Diabetes Reports, vol.96, issue.suppl 3, pp.409-425, 2005. ,
DOI : 10.1007/s11892-005-0047-7
Psychotropic Medication Consumption Patterns in the UK General Population, Journal of Clinical Epidemiology, vol.51, issue.3, 1998. ,
DOI : 10.1016/S0895-4356(97)00238-2
Antidepressants for neuropathic pain, Cochrane Database Syst Rev, issue.3, p.5454, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00557402
Differences in Medication Adherence??and Healthcare Resource??Utilization Patterns, CNS Drugs, vol.177, issue.4, pp.963-73, 2008. ,
DOI : 10.2165/00023210-200822110-00005
Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs, American Journal of Psychiatry, vol.164, issue.6, pp.884-91, 2007. ,
DOI : 10.1176/ajp.2007.164.6.884
Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study, Psychological Medicine, vol.30, issue.5, pp.1217-1242, 2000. ,
DOI : 10.1017/S0033291799002743
Indications for antidepressant drug prescribing in general practice in the Netherlands, Journal of Affective Disorders, vol.98, issue.1-2, 2007. ,
DOI : 10.1016/j.jad.2006.07.003
Indications for and outcome of antidepressant medication in a general population: a prescription database and medical record study, in Jamtland county, Sweden, 1995, Jamtland county, Sweden, pp.427-458, 1995. ,
DOI : 10.1034/j.1600-0447.2002.02432.x
Antidepressant utilisation patterns and determinants of short-term and nonpsychiatric use in the Finnish general adult population, J Affect Disord, 2008. ,
Frequency and adequacy of depression treatment in a Canadian population sample, Can J Psychiatry, vol.52, issue.12, pp.780-789, 2007. ,
Factors influencing depression endpoints research (FINDER): Study design and population characteristics, European Psychiatry, vol.23, issue.1, pp.57-65, 2008. ,
DOI : 10.1016/j.eurpsy.2007.10.002
Americans' Attitudes Toward Mental Health Treatment Seeking: 1990???2003, Psychiatric Services, vol.58, issue.5, pp.642-51, 2007. ,
DOI : 10.1176/ps.2007.58.5.642
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability, Journal of Affective Disorders, vol.58, issue.1, 2000. ,
DOI : 10.1016/S0165-0327(99)00092-0
Psychiatrists' responses to failure of maintenance therapy with antidepressants, Psychiatr Serv, vol.48, issue.6, pp.835-842, 1997. ,
Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians, The Canadian Journal of Psychiatry, vol.43, issue.5, pp.476-81, 2000. ,
DOI : 10.1177/070674370004500509
Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists, Journal of Affective Disorders, vol.43, issue.1, pp.19-25, 1997. ,
DOI : 10.1016/S0165-0327(96)00100-0
Lithium Augmentation in Treatment-Resistant Depression: Meta-Analysis of Placebo-Controlled Studies, Journal of Clinical Psychopharmacology, vol.19, issue.5, 1999. ,
DOI : 10.1097/00004714-199910000-00006
Does Thyroid Hormone Have a Role as Adjunctive Therapy in Depression?1, Thyroid, vol.6, issue.1, pp.63-70, 1996. ,
DOI : 10.1089/thy.1996.6.63
A Novel Augmentation Strategy for Treating Resistant Major Depression, American Journal of Psychiatry, vol.158, issue.1, pp.131-135, 2001. ,
DOI : 10.1176/appi.ajp.158.1.131
Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care, Neuropsychopharmacology, vol.58, issue.12, 2007. ,
DOI : 10.1038/sj.npp.1301390
The STAR*D project results: A comprehensive review of findings, Current Psychiatry Reports, vol.5, issue.Suppl16, 2007. ,
DOI : 10.1007/s11920-007-0061-3
Optimizing outcomes in depression: focus on antidepressant compliance, International Clinical Psychopharmacology, vol.17, issue.6, 2002. ,
DOI : 10.1097/00004850-200211000-00001
Relationship of Total Health Care Charges to Selective Serotonin Reuptake Inhibitor Utilization Patterns Including the Length of Antidepressant Therapy Results From a Managed Care Administrative Claims Database, Journal of Managed Care Pharmacy, vol.11, issue.2, pp.145-50, 2005. ,
DOI : 10.18553/jmcp.2005.11.2.145
Antidepressant Switching Among Adherent Patients Treated for Depression, Psychiatric Services, vol.60, issue.5, pp.617-640, 2009. ,
DOI : 10.1176/ps.2009.60.5.617
Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization, Administration and Policy in Mental Health, vol.30, issue.2, pp.121-160, 2002. ,
DOI : 10.1023/A:1022533118031
Determinants of antidepressant treatment outcome, Am J Manag Care, issue.174, 2000. ,
Persistence, Switching, and Discontinuation Rates Among Patients Receiving Sertraline, Paroxetine, and Citalopram, Pharmacotherapy, vol.58, issue.5, pp.660-667, 2005. ,
DOI : 10.4088/JCP.v60n0902
Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?, Med J Aust Feb, vol.5186, issue.3, pp.142-146, 2007. ,
Medication Augmentation after the Failure of SSRIs for Depression, New England Journal of Medicine, vol.354, issue.12, pp.1243-52, 2006. ,
DOI : 10.1056/NEJMoa052964
National Patterns in Antidepressant Medication Treatment, Archives of General Psychiatry, vol.66, issue.8, pp.848-56, 2009. ,
DOI : 10.1001/archgenpsychiatry.2009.81
Management of access to branded psychotropic medications in private health plans, Clinical Therapeutics, vol.29, issue.2, pp.371-80, 2007. ,
DOI : 10.1016/j.clinthera.2007.02.011
Long-term Outcomes of Initial Antidepressant Drug Choice in a "Real World" Randomized Trial, Archives of Family Medicine, vol.8, issue.4, pp.319-344, 1999. ,
DOI : 10.1001/archfami.8.4.319
Pharmacy and Medical Costs Associated With Switching Between Venlafaxine and SSRI Antidepressant Therapy for the Treatment of Major Depressive Disorder, Journal of Managed Care Pharmacy, vol.14, issue.5, 2008. ,
DOI : 10.18553/jmcp.2008.14.5.426
Oneyear costs of second-line therapies for depression, J Clin Psychiatry, issue.182, 2000. ,
Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder, Psychiatr Serv, 2009. ,
Pharmacotherapy of Depression in Older Patients: A Summary of the Expert Consensus Guidelines, Journal of Psychiatric Practice, vol.7, issue.6, pp.361-76, 2001. ,
DOI : 10.1097/00131746-200111000-00003
Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm, International Journal of Geriatric Psychiatry, vol.283, issue.6, pp.585-92, 2001. ,
DOI : 10.1002/gps.465
Antidepressant treatment for depression: total charges and therapy duration, The Journal of Mental Health Policy and Economics, vol.10, issue.4, pp.187-97, 2000. ,
DOI : 10.1002/mhp.95
Does the Length of the First Antidepressant Treatment Episode Influence Risk and Time to a Second Episode?, Journal of Clinical Psychopharmacology, vol.29, issue.1, pp.69-72, 2009. ,
DOI : 10.1097/JCP.0b013e31819302b1
Antidepressant use and use patterns in naturalistic settings. Drug benefit trends Ref Type: Generic (189) Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database, J Affect Disord, vol.53, issue.1, pp.15-22, 1999. ,
Time to antidepressant discontinuation: a comparison of controlled-release paroxetine and immediate-release selective serotonin-reuptake inhibitors, Manag Care Interface, vol.16, issue.12, pp.22-29, 2003. ,
Continuity of Antidepressant Treatment for Adults With Depression in the United States, American Journal of Psychiatry, vol.163, issue.1, 2006. ,
DOI : 10.1176/appi.ajp.163.1.101
Role of patient experience in antidepressant adherence: A retrospective data analysis, Clinical Therapeutics, vol.30, issue.9, pp.1737-1782, 2008. ,
DOI : 10.1016/j.clinthera.2008.08.014
Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database???, European Psychiatry, vol.25, issue.4, pp.206-219, 2010. ,
DOI : 10.1016/j.eurpsy.2009.07.012
An algorithm to identify antidepressant users with a diagnosis of depression from prescription data, Pharmacoepidemiology and Drug Safety, vol.143, issue.1, pp.7-15, 2009. ,
DOI : 10.1002/pds.1677
Higher Costs and Therapeutic Factors Associated With Adherence to NCQA HEDIS Antidepressant Medication Management Measures: Analysis of Administrative Claims, Journal of Managed Care Pharmacy, vol.12, issue.1, pp.43-54, 2006. ,
DOI : 10.18553/jmcp.2006.12.1.43
Major depression in 1998: are we providing optimal therapy?, J Clin Psychiatry, vol.60, issue.6, pp.5-9, 1999. ,
Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics, Family Practice, vol.21, issue.6, pp.623-632, 2004. ,
DOI : 10.1093/fampra/cmh608
Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization, Am J Manag Care, vol.11, issue.10, pp.621-629, 2005. ,
Duration of Antidepressant Drug Treatment and Its Influence on Risk of Relapse/Recurrence: Immortal and Neglected Time Bias, American Journal of Epidemiology, vol.170, issue.3, pp.280-285, 2009. ,
DOI : 10.1093/aje/kwp142
A 5-year follow-up of general practice patients experiencing depression, Family Practice, vol.20, issue.6, pp.685-694, 2003. ,
DOI : 10.1093/fampra/cmg611
Cost-effectiveness of antidepressant medications, The Journal of Mental Health Policy and Economics, vol.1, issue.3, pp.109-126, 1998. ,
DOI : 10.1002/(SICI)1099-176X(1998100)1:3<109::AID-MHP15>3.0.CO;2-2
The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs, The Journal of Clinical Psychiatry, vol.63, issue.11, pp.963-71, 2002. ,
DOI : 10.4088/JCP.v63n1102
Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care, General Hospital Psychiatry, vol.27, issue.4, pp.229-265, 2005. ,
DOI : 10.1016/j.genhosppsych.2005.04.001
Characteristics and Reasons Associated with Nonacceptance of Selective Serotonin-Reuptake Inhibitor Treatment, Annals of Pharmacotherapy, vol.22, issue.2, pp.218-243, 2008. ,
DOI : 10.1345/aph.1K516
Clinical validity of a population database definition of remission in patients with major depression, BMC Public Health, vol.57, issue.Supl 1, p.64, 2010. ,
DOI : 10.1192/bjp.179.4.317